Home Cart 0 Sign in  

[ CAS No. 1221239-09-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 1221239-09-3
Chemical Structure| 1221239-09-3
Structure of 1221239-09-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1221239-09-3 ]

Related Doc. of [ 1221239-09-3 ]

Alternatived Products of [ 1221239-09-3 ]

Product Details of [ 1221239-09-3 ]

CAS No. :1221239-09-3 MDL No. :MFCD18205310
Formula : C15H20BNO3 Boiling Point : -
Linear Structure Formula :- InChI Key :IAKVXXCASRMULQ-UHFFFAOYSA-N
M.W : 273.14 Pubchem ID :53407631
Synonyms :

Calculated chemistry of [ 1221239-09-3 ]

Physicochemical Properties

Num. heavy atoms : 20
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.53
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 82.78
TPSA : 38.77 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.59 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.0
Log Po/w (XLOGP3) : 1.94
Log Po/w (WLOGP) : 1.04
Log Po/w (MLOGP) : 1.39
Log Po/w (SILICOS-IT) : 1.67
Consensus Log Po/w : 1.21

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.91
Solubility : 0.335 mg/ml ; 0.00123 mol/l
Class : Soluble
Log S (Ali) : -2.38
Solubility : 1.14 mg/ml ; 0.00418 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.16
Solubility : 0.0189 mg/ml ; 0.0000693 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 2.87

Safety of [ 1221239-09-3 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1221239-09-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 1221239-09-3 ]

[ 1221239-09-3 ] Synthesis Path-Downstream   1~2

YieldReaction ConditionsOperation in experiment
81% With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate In N,N-dimethyl acetamide at 100℃; for 2h; Inert atmosphere; 7-3 Preparation 7-1. 4-(4,4,5,5-Tetramethyl-l,3,2-dioxaborolan-2-yl)-indan-l- one. General procedure: Preparation 7-1. 4-(4,4,5,5-Tetramethyl-l,3,2-dioxaborolan-2-yl)-indan-l- one. [00122] To a solution of 4-bromo-l-indanone (1.0 g, 4.74 mmol) in N,N- dimethylacetamide (25 mL) was added bw(pinacolato)diboron (2.41 g, 9.48 mmol), 1,1 '- ^w(diphenylphosphino)ferrocene palladium(II) dichloride (346 mg, 0.47 mmol) and potassium acetate (1.40 g, 14.22 mmol) and the reaction mixture was stirred at 100 °C for 2 h under nitrogen. The mixture was evaporated and the residue was diluted with water (50 mL) and extracted with dichloromethane (3 x 50 mL). The combined organic layers were dried over sodium sulfate and evaporated. The residue was purified by column chromatography eluting with hexane: ethyl acetate (100:0->4: 1) to give the title compound (1.8 g, 7.00 mmol, ca. 100%) as an off-white powder. LCMS: 97%, Rt 1.811 , ESMS m/z 259 (M+H-CH4)+.
81% With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate In N,N-dimethyl acetamide at 100℃; for 2h; Inert atmosphere; 7-3 Preparation 7-1. 4-(4,4,5,5-Tetramethyl- 1,3 ,2-dioxaborolan-2-yl)-indan- 1-one. General procedure: To a solution of 4-bromo-l-indanone (1.0 g, 4.74 mmol) in N,Ndimethylacetamide (25 mL) was added bis(pinacolato)diboron (2.41 g, 9.48 mmol), 1,1’-bis(diphenylphosphino)ferrocene palladium(11) dichloride (346 mg, 0.47 mmol) and potassiumacetate (1.40 g, 14.22 mmol) and the reaction mixture was stirred at 100 °C for 2 h undernitrogen. The mixture was evaporated and the residue was diluted with water (50 mL) andextracted with dichloromethane (3 x 50 mL). The combined organic layers were dried oversodium sulfate and evaporated. The residue was purified by column chromatography eluting withhexane:ethyl acetate (100:0-4:1) to give the title compound (1.8 g, 7.00 mmol, Ca. 100%) as anoff-white powder. LCMS: 97%, Rt 1.811, ESMS m/z 259 (M+H-CH4).
81% With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate In N,N-dimethyl acetamide at 100℃; for 2h; Inert atmosphere; 7-3 Preparation 7-1. 4-(4,4,5,5-Tetramethyl- 1 ,3,2-dioxaborolan-2-yI)-indan- 1-one. General procedure: [00116] To a solution of 4-bromo-1-indanone (1.0 g, 4.74 mmol) in N,Ndimethylacetamide (25 mL) was added bis(pinacolato)diboron (2.41 g, 9.48 mmol), 1,1’- bis(diphenylphosphino)ferrocene palladium(II) dichloride (346 mg, 0.47 mmol) and potassium acetate (1.40 g, 14.22 mmol) and the reaction mixture was stirred at 100 °C for 2 h under nitrogen. The mixture was evaporated and the residue was diluted with water (50 mL) and extracted with dichloromethane (3 x 50 mE). The combined organic layers were dried over sodium sulfate and evaporated. The residue was purified by column chromatography eluting with hexane:ethyl acetate (100:0-)4:1) to give the title compound (1.8 g, 7.00 mmol, Ca. 100%) as an off-white powder
  • 2
  • [ 5342-91-6 ]
  • [ 73183-34-3 ]
  • [ 1221239-09-3 ]
  • [ CAS Unavailable ]
YieldReaction ConditionsOperation in experiment
With (1,5-cyclooctadiene)(methoxy)iridium(I) dimer; 4,4'-di-tert-butyl-2,2'-bipyridine In para-xylene at 35℃; for 24h; Overall yield = 54 %Spectr.; regioselective reaction;
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 1221239-09-3 ]

Organoboron

Chemical Structure| 1313399-38-0

[ 1313399-38-0 ]

2-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoindolin-1-one

Similarity: 0.94

Chemical Structure| 376584-62-2

[ 376584-62-2 ]

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)isoindolin-1-one

Similarity: 0.92

Chemical Structure| 1004294-80-7

[ 1004294-80-7 ]

6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)isoindolin-1-one

Similarity: 0.92

Chemical Structure| 935660-75-6

[ 935660-75-6 ]

N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzamide

Similarity: 0.86

Chemical Structure| 179117-44-3

[ 179117-44-3 ]

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

Similarity: 0.84

Amides

Chemical Structure| 1313399-38-0

[ 1313399-38-0 ]

2-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoindolin-1-one

Similarity: 0.94

Chemical Structure| 376584-62-2

[ 376584-62-2 ]

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)isoindolin-1-one

Similarity: 0.92

Chemical Structure| 1004294-80-7

[ 1004294-80-7 ]

6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)isoindolin-1-one

Similarity: 0.92

Chemical Structure| 935660-75-6

[ 935660-75-6 ]

N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzamide

Similarity: 0.86

Chemical Structure| 179117-44-3

[ 179117-44-3 ]

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

Similarity: 0.84

Related Parent Nucleus of
[ 1221239-09-3 ]

Indolines

Chemical Structure| 1313399-38-0

[ 1313399-38-0 ]

2-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoindolin-1-one

Similarity: 0.94

Chemical Structure| 376584-62-2

[ 376584-62-2 ]

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)isoindolin-1-one

Similarity: 0.92

Chemical Structure| 1004294-80-7

[ 1004294-80-7 ]

6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)isoindolin-1-one

Similarity: 0.92

Chemical Structure| 1220696-38-7

[ 1220696-38-7 ]

1-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indolin-2-one

Similarity: 0.77

Chemical Structure| 893441-85-5

[ 893441-85-5 ]

6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)indolin-2-one

Similarity: 0.76